REGISTERED
on 31 May 2022
Last Applicant/ Owned by
1061 Serpentine Ln., Suite E
Pleasanton
CA
94566
Serial Number
90713374 filed on 15th May 2021
Registration Number
6743350 registered on 31st May 2022
Correspondent Address
Micah Drayton
Filing Basis
1. use application currently
Disclaimer
NO DATA
IFORMULATE
Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using adv Read More
Classification Information
Class [001]
Chemical Products
Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (ADCs), all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of pH, ionic strength, buffer and stability concentrations, all the foregoing using Design of Experiments Approach in a multivariate fashion
First Use Date in General
28th Jun 2010
First Use Date in Commerce
28th Jun 2010
Class [042]
Computer & Software Services & Scientific Services
Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy
First Use Date in General
28th Mar 2010
First Use Date in Commerce
28th Jun 2010
Mark Details
Serial Number
No 90713374
Mark Type
No Service Mark
Attorney Docket Number
No 1136-001UST1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Apr 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 20th Apr 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 20th Apr 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 20th Apr 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 31st May 2022 | REGISTERED-PRINCIPAL REGISTER |
| 31st May 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 15th Mar 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 15th Mar 2022 | PUBLISHED FOR OPPOSITION |
| 23rd Feb 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 10th Feb 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |